Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Status:
Recruiting
Trial end date:
2025-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this open label,single arm,phase Ⅱ clinical trail is to determine the safety
and efficacy of Chidamide combination with lenalidomide for relapsed or refractory peripheral
T-cell lymphoma.